EichorEICHOR
Condition: Stage Ii Iii Synced from ClinicalTrials.gov · August 04, 2026

Recruiting studies: Stage Ii Iii

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NEO100 and High-Grade Meningioma
Phase 2 · 5 location(s) · Neonc Technologies, Inc. · NCT05023018
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
Phase 3 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07029217
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
Phase 3 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT03949231
Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung C
Phase 2 · 1 location(s) · Fondazione Ricerca Traslazionale · NCT05568212
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
Phase 2/Phase 3 · 1 location(s) · Children's Cancer Group, China · NCT06563245
SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer
Phase 2/Phase 3 · 1 location(s) · Sinocelltech Ltd. · NCT07662395
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition Af
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT03942328
Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Phase 2 · 1 location(s) · Marzieh Ebrahimi · NCT06687681
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascula
EARLY_Phase 1 · 1 location(s) · Emory University · NCT06914999
Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL
Phase 2/Phase 3 · 1 location(s) · National University of Malaysia · NCT03937544
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastr
Phase 2/Phase 3 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07165886
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colore
Phase 3 · 384 location(s) · SWOG Cancer Research Network · NCT07018869
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
Phase 2 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT04562129
A Study of Picankibart in Patients With Active Psoriatic Arthritis
Phase 2/Phase 3 · 1 location(s) · Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. · NCT07295509
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NA · 4 location(s) · Dana-Farber Cancer Institute · NCT05535192
A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally
Phase 2/Phase 3 · 2 location(s) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07454720
Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly A
Phase N/A · 1 location(s) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di · NCT07420790
Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy
Phase 3 · 5 location(s) · Dr. Tabassum Wadasadawala · NCT06926543
Neoadjuvant Breast Cancer Time Restricted Eating
NA · 1 location(s) · Thomas Jefferson University · NCT05327608
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07094685
Phase II Trial of Immunonutrition in Hepatectomy
NA · 1 location(s) · Tata Memorial Centre · NCT07395635
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT05194878
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-
Phase 3 · 1 location(s) · Shanghai Chest Hospital · NCT06437977
Early Detection of Advanced Adenomas and Colorectal Cancer
Phase N/A · 6 location(s) · City of Hope Medical Center · NCT06342440
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Phase 2 · 10 location(s) · Memorial Sloan Kettering Cancer Center · NCT04165772
TRUDI: TDXD+Durva in HER2+/Low IBC
Phase 2 · 3 location(s) · Filipa Lynce, MD · NCT05795101
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
NA · 2 location(s) · University of Southern California · NCT06500169
Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectabl
Phase 2 · 1 location(s) · Tongji University · NCT06304350
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
Phase 2 · 2 location(s) · University of Iowa · NCT05239546
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Phase 2 · 20 location(s) · Fundación GECP · NCT05398094
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →